BIOMAT Database Logo BIOMAT Database Logo

[Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis]. 1967

M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013307 Streptomycin An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis. Estreptomicina CEPA,Estreptomicina Clariana,Estreptomicina Normon,Strepto-Fatol,Strepto-Hefa,Streptomycin Grünenthal,Streptomycin Sulfate,Streptomycin Sulfate (2:3) Salt,Streptomycin Sulphate,Streptomycine Panpharma,Strepto Fatol,Strepto Hefa
D014756 Viomycin A strongly basic peptide, antibiotic complex from several strains of Streptomyces. It is allergenic and toxic to kidneys and the labyrinth. Viomycin is used in tuberculosis as several different salts and in combination with other agents. Florimycin,Tuberactinomycin B,Celiomycin,Vinactane,Viocin,Viomicin,Viomycins

Related Publications

M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura
[Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
April 1970, Antibiotiki,
M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura
[Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
June 1971, Rinsho byori. The Japanese journal of clinical pathology,
M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura
Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
August 2005, Antimicrobial agents and chemotherapy,
M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura
Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
March 1977, Tubercle,
M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura
[Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
June 1969, Kekkaku : [Tuberculosis],
M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura
[Antituberculous activity of capreomycin and cross resistance to kanamycin, capreomycin, and viomycin. 2. In vitro study of cross resistance to capreomycin, kanamycin and viomycin].
September 1969, Bulletin of the Chest Disease Research Institute, Kyoto University,
M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura
Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.
June 2009, Indian journal of experimental biology,
M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura
Drug-resistance test for kanamycin and cross resistance problem in Mycobacterium tuberculosis with special reference to kanamycin, streptomycin, and viomycin.
July 1959, The Journal of antibiotics,
M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura
Further studies on cross resistance in Mycobacterium tuberculosis, with special reference to streptomycin-, kanamycin-, and viomycin resistance.
March 1962, The American review of respiratory disease,
M Tsukamura, and H Toyama, and S Mizuno, and S Tsukamura
[Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
August 1970, The Japanese journal of antibiotics,
Copied contents to your clipboard!